AEON 5 LIMITED
Significant control: Emma Jayne Tinsley (75–100%), Professor Houman Ashrafian (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Aeon 5 Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Aeon 5 Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
AEON 5 LIMITED is an active private limited company (company number 14717628) incorporated on 8 March 2023, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £202, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 10000% on the prior period (£2).
By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Ms Emma Jayne Tinsley
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Professor Houman Ashrafian
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 8 March 20233 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 22 March 2027in 149 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £202 | — | — | — | — | — | 0 |
| 31 March 2024 | £2 | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £202 at 31 March 2025
- Net assets up 10% or more on the prior period+10000.0% vs prior period
- Incorporated two to five years agoIncorporated 8 March 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 149 days
- Next accounts duein 68 days
- Accounts period endNet assets £202 · micro accounts
- Accounts period endNet assets £2 · micro accounts
- Incorporated
Similar companies in London
- AXOVIA THERAPEUTICS LTDLondon · inc. Mar 2023
- BYRD BIOSCIENCES LTDLondon · inc. Mar 2023
- ZONOVA TECHNOLOGIES LTDLondon · inc. Mar 2023
- WOODSIDE UROL HEALTH LIMITEDLondon · inc. Mar 2023
- VANTAGE BIOSCIENCES LTDLondon · inc. Mar 2023
- MBPHARMACO CONSULTING LTDLondon · inc. Mar 2023
All companies incorporated on 8 March 2023 · in Mar 2023.
Reminders for AEON 5 LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.